Visalytics
Visalytics
approved EB-2 (NIW)

Research Assistant Professor

Immunology · India · 2022-07-27

Processing Time
184 days
Decision Date
2022-07-27
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to continue her research in immunology, specifically focusing on leishmaniasis and inflammatory bowel diseases. Her work involves developing novel plant-based immunomodulatory therapies and utilizing techniques like flow cytometry to improve treatment strategies for parasitic and inflammatory conditions.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The research into disease processes of infection, inflammation, and carcinogenesis addresses some of the nation's most pressing health issues.

2 Well-positioned to Advance the Endeavor Met

The petitioner is well-positioned due to her Ph.D., extensive publication record in prominent journals, and high citation count.

3 Waiver of Job Offer and Labor Certification Met

On balance, it is beneficial to the U.S. to waive the requirements given the petitioner's original contributions to mucosal immunology and treatment of leishmaniasis.

Why This Petition Was Approved

The petition was approved based on the petitioner's Ph.D. in biochemistry and her record of 48 peer-reviewed articles and 1 editorial which accumulated 1,901 citations from researchers in 76 countries. Additionally, she conducted 30 peer reviews, served on an editorial board, and provided 4 expert recommendation letters satisfying the Dhanasar prongs for NIW and extraordinary ability criteria for EB-1A.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Reference Letters Independent
Judging Experience
Original Contributions

Similar Cases

Postdoctoral Researcher

Biotechnology · China

WeGreened EB-2 (NIW) approved
Ohio 90 days 2025-01-24
The petitioner proposes to continue his research into the role of immune cells in human diseases, specifically focusing on autoimmunity and tumors. His work aims to develop novel immunotherapies for Diffuse Intrinsic Pontine Glioma (DIPG) and identify new therapeutic targets to improve treatments for cancer and autoimmune conditions.
View Case

Clinical Research Coordinator

Biotechnology · Pakistan

WeGreened EB-2 (NIW) approved
Michigan 47 days 2025-05-12
The petitioner proposes to advance disease prevention and treatment strategies, specifically focusing on inflammatory bowel disease, heart disease, autoimmune disorders, and novel infections. The work involves optimizing and synthesizing predictive, therapeutic, and diagnostic modalities to improve clinical outcomes for pressing health issues.
View Case

Research Scientist

Biotechnology · China

WeGreened EB-2 (NIW) rfe approved
213 days 2025-07-08
The petitioner proposes to use multi-omics tools to investigate disease mechanisms, specifically focusing on inflammatory bowel disease (IBD) and gastrointestinal cancers. This work aims to develop healthcare solutions for chronic conditions and improve public health outcomes through precision medicine.
View Case

Research Scientist

Biotechnology · China

WeGreened EB-2 (NIW) approved
California 354 days 2025-04-03
The petitioner proposes to advance the identification of new therapeutic targets for cancer, autoimmune diseases, and chronic inflammatory conditions using high-throughput technologies like single-cell sequencing. Her work focuses on examining T cell behavior within tumor microenvironments and immune responses to vaccines and cancer treatments to develop cost-effective strategies for immune modulation.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Biotechnology cases More cases from India

Case data sourced from publicly available petition decisions and case studies. Decision date: 2022-07-27.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 184 days
Criteria Met 3 / 3
Evidence Types 5

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,895
Success Rate 54.2%
Sustained 2,112
Dismissed 1,687

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in India All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist